Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis

Aaron Tan, Gillianne Lai, Gek Tan, Shou Poon, Brett Doble, Tse Lim, Zaw Aung, Angela Takano, Wan Tan, Mei-Kim Ang, Bien Tan, Anantham Devanand, Chow Too, Apoorva Gogna, Boon-Hean Ong, Tina Koh, Ravindran Kanesvaran, Quan Ng, Amit Jain, Tanujaa Rajasekaran, Alvin Lim, Wan Lim, Chee Toh, Eng-Huat Tan, Tony Lim, Daniel Tan (2020) Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis Lung Cancer (IF: 4.4) 139 207-215

Links

http://www.ncbi.nlm.nih.gov/pubmed/31835042
http://dx.doi.org/10.1016/j.lungcan.2019.11.022

Similar articles

Tools

Export to RIS